PNR
30
-2
CCI
39
9
CAT
55
-2
NAVI
40
2
WM
80
6
AMGN
39
-5
PBI
42
-4
CNP
70
2
LNC
40
-2
MS
61
2
FSLR
49
-3
QRVO
59
6
CLX
42
-3
IR
35
-3
GM
57
-6
ETN
55
-2
NDAQ
57
2
GE
55
-5
CMG
41
3
PEP
56
3
PNR
30
-2
CCI
39
9
CAT
55
-2
NAVI
40
2
WM
80
6
AMGN
39
-5
PBI
42
-4
CNP
70
2
LNC
40
-2
MS
61
2
FSLR
49
-3
QRVO
59
6
CLX
42
-3
IR
35
-3
GM
57
-6
ETN
55
-2
NDAQ
57
2
GE
55
-5
CMG
41
3
PEP
56
3
Financhill
Back

Putnam Focused Large Cap Value ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
52

PVAL
Putnam Focused Large Cap Value ETF

Last Price:
$46.69
Seasonality Move:
0.57%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Buy
52
Putnam Focused Large Cap Value ETF (PVAL) is a Buy

Is Putnam Focused Large Cap Value ETF a Buy, Sell or Hold?

  • The current Putnam Focused Large Cap Value ETF [PVAL] share price is $46.63. The Score for PVAL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • PVAL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

PVAL Stock Price Chart

What is Putnam Focused Large Cap Value ETF's stock price today?

  • The Putnam Focused Large Cap Value ETF share price today is $46.63
    The current trend is relatively stagnant and PVAL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PVAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 50.06 Buy
Chaikin Money Flow: 926450 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.82 - 47.4) Buy
Bollinger Bands (100): (44.71 - 47.83) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

PVAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.22 Buy
20-day SMA: 46.26 Buy
50-day SMA: 47.35 Sell
200-day SMA: 43.95 Buy
8-day EMA: 46.28 Buy
20-day EMA: 46.48 Buy
50-day EMA: 46.72 Sell
200-day EMA: 44.23 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Putnam Focused Large Cap Value ETF Earnings Growth & PVAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Putnam Focused Large Cap Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):